Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib

Recent case reports provided alarming signals that treatment with bortezomib might be associated with cardiac events. In all reported cases, patients experiencing cardiac problems were previously or concomitantly treated with other chemotherapeutics including cardiotoxic anthracyclines. Therefore, i...

Full description

Saved in:
Bibliographic Details
Main Authors: Nowis, Dominika, Mączewski, Michał, Mackiewicz, Urszula, Kujawa, Marek, Ratajska, Anna, Wieckowski, Mariusz R., Wilczyński, Grzegorz M., Malinowska, Monika, Bil, Jacek, Salwa, Paweł, Bugajski, Marek, Wójcik, Cezary, Siński, Maciej, Abramczyk, Piotr, Winiarska, Magdalena, Dąbrowska-Iwanicka, Anna, Duszyński, Jerzy, Jakóbisiak, Marek, Golab, Jakub
Format: Artigo
Language:Inglês
Published: American Society for Investigative Pathology 2010
Subjects:
Regular Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2877829/
https://ncbi.nlm.nih.gov/pubmed/20519734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2010.090690
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items